메뉴 건너뛰기




Volumn 10, Issue 7, 2015, Pages

Atrial fibrillation is associated with a marker of endothelial function and oxidative stress in patients with acute myocardial infarction

Author keywords

[No Author keywords available]

Indexed keywords

6 N,N' DIMETHYLARGININE; ACETYLSALICYLIC ACID; AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; N(G),N(G) DIMETHYLARGININE; ARGININE; BIOLOGICAL MARKER; N,N-DIMETHYLARGININE;

EID: 84941283144     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0131439     Document Type: Article
Times cited : (24)

References (39)
  • 2
    • 79957509557 scopus 로고    scopus 로고
    • Atrial fibrillation and death after myocardial infarction: A community study
    • Jabre P, Jouven X, Adnet F, Thabut G, Bielinski SJ, Weston SA et al. Atrial fibrillation and death after myocardial infarction: A community study. Circulation. 2011;123:2094-2100.
    • (2011) Circulation , vol.123 , pp. 2094-2100
    • Jabre, P.1    Jouven, X.2    Adnet, F.3    Thabut, G.4    Bielinski, S.J.5    Weston, S.A.6
  • 3
    • 65949090068 scopus 로고    scopus 로고
    • Atrial fibrillation in acute myocardial infarction: A systematic review of the incidence, clinical features and prognostic implications
    • Schmitt J, Duray G, Gersh BJ, Hohnloser SH. Atrial fibrillation in acute myocardial infarction: A systematic review of the incidence, clinical features and prognostic implications. Eur Heart J. 2009;30:1038-1045.
    • (2009) Eur Heart J , vol.30 , pp. 1038-1045
    • Schmitt, J.1    Duray, G.2    Gersh, B.J.3    Hohnloser, S.H.4
  • 4
    • 84903304206 scopus 로고    scopus 로고
    • Incidence and prognostic significance of silent atrial fibrillation in acute myocardial infarction
    • Stamboul K, Zeller M, Fauchier L, Gudjoncik A, Buffet P, Garnier F et al. Incidence and prognostic significance of silent atrial fibrillation in acute myocardial infarction. Int J Cardiol. 2014;174:611-617.
    • (2014) Int J Cardiol. , vol.174 , pp. 611-617
    • Stamboul, K.1    Zeller, M.2    Fauchier, L.3    Gudjoncik, A.4    Buffet, P.5    Garnier, F.6
  • 7
    • 84885484473 scopus 로고    scopus 로고
    • Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: Possible therapeutic targets?
    • Rochette L, Lorin J, Zeller M, Guilland JC, Lorgis L, Cottin Y et al. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: Possible therapeutic targets? Pharmacol Ther. 2013;140:239-257.
    • (2013) Pharmacol Ther , vol.140 , pp. 239-257
    • Rochette, L.1    Lorin, J.2    Zeller, M.3    Guilland, J.C.4    Lorgis, L.5    Cottin, Y.6
  • 8
    • 33645501775 scopus 로고    scopus 로고
    • Asymmetric dimethylarginine (adma): A novel risk marker in cardiovascular medicine and beyond
    • Boger RH. Asymmetric dimethylarginine (adma): A novel risk marker in cardiovascular medicine and beyond. Ann Med. 2006;38:126-136.
    • (2006) Ann Med , vol.38 , pp. 126-136
    • Boger, R.H.1
  • 9
    • 77951642455 scopus 로고    scopus 로고
    • The role of asymmetric dimethylarginine (adma) in endothelial dysfunction and cardiovascular disease
    • Sibal L, Agarwal SC, Home PD, Boger RH. The role of asymmetric dimethylarginine (adma) in endothelial dysfunction and cardiovascular disease. Curr Cardiol Rev. 2010;6:82-90.
    • (2010) Curr Cardiol Rev. , vol.6 , pp. 82-90
    • Sibal, L.1    Agarwal, S.C.2    Home, P.D.3    Boger, R.H.4
  • 10
    • 0031424947 scopus 로고    scopus 로고
    • Interference of l-arginine analogues with l-arginine transport mediated by the y+ carrier hcat-2b
    • Closs EI, Basha FZ, Habermeier A, Forstermann U. Interference of l-arginine analogues with l-arginine transport mediated by the y+ carrier hcat-2b. Nitric oxide. 1997;1:65-73.
    • (1997) Nitric Oxide , vol.1 , pp. 65-73
    • Closs, E.I.1    Basha, F.Z.2    Habermeier, A.3    Forstermann, U.4
  • 11
    • 0041357001 scopus 로고    scopus 로고
    • Endothelial dysfunction induced by hyperhomocyst (e) inemia: Role of asymmetric dimethylarginine
    • Stuhlinger MC, Oka RK, Graf EE, Schmolzer I, Upson BM, Kapoor O et al. Endothelial dysfunction induced by hyperhomocyst (e) inemia: Role of asymmetric dimethylarginine. Circulation. 2003;108:933-938.
    • (2003) Circulation , vol.108 , pp. 933-938
    • Stuhlinger, M.C.1    Oka, R.K.2    Graf, E.E.3    Schmolzer, I.4    Upson, B.M.5    Kapoor, O.6
  • 12
    • 1642453719 scopus 로고    scopus 로고
    • Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans
    • Kielstein JT, Impraim B, Simmel S, Bode-Boger SM, Tsikas D, Frolich JC et al. Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans. Circulation. 2004;109:172-177.
    • (2004) Circulation , vol.109 , pp. 172-177
    • Kielstein, J.T.1    Impraim, B.2    Simmel, S.3    Bode-Boger, S.M.4    Tsikas, D.5    Frolich, J.C.6
  • 13
    • 0041733065 scopus 로고    scopus 로고
    • Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase
    • Achan V, Broadhead M, Malaki M, Whitley G, Leiper J, MacAllister R et al. Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase. Arterioscler Thromb Vasc Biol. 2003;23:1455-1459.
    • (2003) Arterioscler Thromb Vasc Biol. , vol.23 , pp. 1455-1459
    • Achan, V.1    Broadhead, M.2    Malaki, M.3    Whitley, G.4    Leiper, J.5    MacAllister, R.6
  • 14
    • 4444248826 scopus 로고    scopus 로고
    • Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: Involvement of renin-angiotensin system and oxidative stress
    • Suda O, Tsutsui M, Morishita T, Tasaki H, Ueno S, Nakata S et al. Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: Involvement of renin-angiotensin system and oxidative stress. Arterioscler Thromb Vasc Biol. 2004;24:1682-1688.
    • (2004) Arterioscler Thromb Vasc Biol. , vol.24 , pp. 1682-1688
    • Suda, O.1    Tsutsui, M.2    Morishita, T.3    Tasaki, H.4    Ueno, S.5    Nakata, S.6
  • 15
    • 27744511357 scopus 로고    scopus 로고
    • Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: Results from the atherogene study
    • Schnabel R, Blankenberg S, Lubos E, Lackner KJ, Rupprecht HJ, Espinola-Klein C et al. Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: Results from the atherogene study. Circ Res. 2005;97:e53-59.
    • (2005) Circ Res , vol.97 , pp. e53-e59
    • Schnabel, R.1    Blankenberg, S.2    Lubos, E.3    Lackner, K.J.4    Rupprecht, H.J.5    Espinola-Klein, C.6
  • 20
    • 84881329752 scopus 로고    scopus 로고
    • Plasma asymmetric dimethylarginine and adverse events in patients with atrial fibrillation referred for coronary angiogram
    • Chao TF, Lu TM, Lin YJ, Tsao HM, Chang SL, Lo LW, et al. Plasma asymmetric dimethylarginine and adverse events in patients with atrial fibrillation referred for coronary angiogram. PloS one. 2013;8:e71675.
    • (2013) PloS One , vol.8 , pp. e71675
    • Chao, T.F.1    Lu, T.M.2    Lin, Y.J.3    Tsao, H.M.4    Chang, S.L.5    Lo, L.W.6
  • 22
    • 77956458757 scopus 로고    scopus 로고
    • HPLC determination of plasma dimethylarginines: Method validation and preliminary clinical application
    • Ivanova M, Artusi C, Boffa GM, Zaninotto M, Plebani M. HPLC determination of plasma dimethylarginines: Method validation and preliminary clinical application. Clin Chim Acta. 2010;411:1632-1636.
    • (2010) Clin Chim Acta , vol.411 , pp. 1632-1636
    • Ivanova, M.1    Artusi, C.2    Boffa, G.M.3    Zaninotto, M.4    Plebani, M.5
  • 23
    • 84878798260 scopus 로고    scopus 로고
    • High levels of asymmetric dimethylarginine are strongly associated with low hdl in patients with acute myocardial infarction
    • Lorin J, Guilland JC, Korandji C, Touzery C, Bichat F, Chagnon A et al. High levels of asymmetric dimethylarginine are strongly associated with low hdl in patients with acute myocardial infarction. PloS one. 2013;8:e64796.
    • (2013) PloS One , vol.8 , pp. e64796
    • Lorin, J.1    Guilland, J.C.2    Korandji, C.3    Touzery, C.4    Bichat, F.5    Chagnon, A.6
  • 24
    • 77957699729 scopus 로고    scopus 로고
    • Guidelines for the management of atrial fibrillation: The task force for the management of atrial fibrillation of the european society of cardiology (ESC)
    • Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S et al. Guidelines for the management of atrial fibrillation: The task force for the management of atrial fibrillation of the european society of cardiology (esc). Eur Heart J. 2010;31:2369-2429.
    • (2010) Eur Heart J , vol.31 , pp. 2369-2429
    • Camm, A.J.1    Kirchhof, P.2    Lip, G.Y.3    Schotten, U.4    Savelieva, I.5    Ernst, S.6
  • 25
    • 65249184373 scopus 로고    scopus 로고
    • Role of symmetric dimethylarginine in vascular damage by increasing ros via store-operated calcium influx in monocytes
    • Schepers E, Glorieux G, Dhondt A, Leybaert L, Vanholder R. Role of symmetric dimethylarginine in vascular damage by increasing ros via store-operated calcium influx in monocytes. Nephrol Dial Transplant. 2009;24:1429-1435.
    • (2009) Nephrol Dial Transplant , vol.24 , pp. 1429-1435
    • Schepers, E.1    Glorieux, G.2    Dhondt, A.3    Leybaert, L.4    Vanholder, R.5
  • 26
    • 79955623424 scopus 로고    scopus 로고
    • The role of asymmetric and symmetric dimethylarginines in renal disease
    • Schwedhelm E, Boger RH. The role of asymmetric and symmetric dimethylarginines in renal disease. Nat Rev Nephrol. 2011;7:275-285.
    • (2011) Nat Rev Nephrol. , vol.7 , pp. 275-285
    • Schwedhelm, E.1    Boger, R.H.2
  • 27
    • 70449705942 scopus 로고    scopus 로고
    • Effects of rosuvastatin on asymmetric dimethylarginine levels and early atrial fibrillation recurrence after electrical cardioversion
    • Xia W, Yin Z, Li J, Song Y, Qu X. Effects of rosuvastatin on asymmetric dimethylarginine levels and early atrial fibrillation recurrence after electrical cardioversion. Pacing Clin Electrophysiol. 2009;32:1562-1566.
    • (2009) Pacing Clin Electrophysiol. , vol.32 , pp. 1562-1566
    • Xia, W.1    Yin, Z.2    Li, J.3    Song, Y.4    Qu, X.5
  • 28
    • 84855658119 scopus 로고    scopus 로고
    • Asymmetric dimethylarginine concentration and recurrence of atrial tachyarrythmias after catheter ablation in patients with persistent atrial fibrillation
    • Yang L, Xiufen Q, Shuqin S, Yang Y, Ying S, Yanwei Y et al. Asymmetric dimethylarginine concentration and recurrence of atrial tachyarrythmias after catheter ablation in patients with persistent atrial fibrillation. J Interv Card Electrophysiol. 2011;32:147-154.
    • (2011) J Interv Card Electrophysiol. , vol.32 , pp. 147-154
    • Yang, L.1    Xiufen, Q.2    Shuqin, S.3    Yang, Y.4    Ying, S.5    Yanwei, Y.6
  • 29
    • 0032557388 scopus 로고    scopus 로고
    • Increased endogenous nitric oxide synthase inhibitor in patients with congestive heart failure
    • Usui M, Matsuoka H, Miyazaki H, Ueda S, Okuda S, Imaizumi T. Increased endogenous nitric oxide synthase inhibitor in patients with congestive heart failure. Life Sci. 1998;62:2425-2430.
    • (1998) Life Sci. , vol.62 , pp. 2425-2430
    • Usui, M.1    Matsuoka, H.2    Miyazaki, H.3    Ueda, S.4    Okuda, S.5    Imaizumi, T.6
  • 32
    • 84861531896 scopus 로고    scopus 로고
    • Endogenous nitric oxide synthase inhibitors in the biology of disease: Markers, mediators, and regulators?
    • Caplin B, Leiper J. Endogenous nitric oxide synthase inhibitors in the biology of disease: Markers, mediators, and regulators? Arterioscler Thromb Vasc Biol. 2012;32:1343-1353.
    • (2012) Arterioscler Thromb Vasc Biol. , vol.32 , pp. 1343-1353
    • Caplin, B.1    Leiper, J.2
  • 33
    • 83455230998 scopus 로고    scopus 로고
    • Pathogenic cycle between the endogenous nitric oxide synthase inhibitor asymmetrical dimethylarginine and the leukocyte-derived hemoprotein myeloperoxidase
    • Von Leitner EC, Klinke A, Atzler D, Slocum JL, Lund N, Kielstein JT et al. Pathogenic cycle between the endogenous nitric oxide synthase inhibitor asymmetrical dimethylarginine and the leukocyte-derived hemoprotein myeloperoxidase. Circulation. 2011;124:2735-2745.
    • (2011) Circulation , vol.124 , pp. 2735-2745
    • Von Leitner, E.C.1    Klinke, A.2    Atzler, D.3    Slocum, J.L.4    Lund, N.5    Kielstein, J.T.6
  • 34
    • 65949123566 scopus 로고    scopus 로고
    • Association of plasma asymmetrical dimethylarginine (adma) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: Implications for endothelial function in human atherosclerosis
    • Antoniades C, Shirodaria C, Leeson P, Antonopoulos A, Warrick N, Van-Assche T et al. Association of plasma asymmetrical dimethylarginine (adma) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: Implications for endothelial function in human atherosclerosis. Eur Heart J. 2009;30:1142-1150.
    • (2009) Eur Heart J , vol.30 , pp. 1142-1150
    • Antoniades, C.1    Shirodaria, C.2    Leeson, P.3    Antonopoulos, A.4    Warrick, N.5    Van-Assche, T.6
  • 35
    • 84885795044 scopus 로고    scopus 로고
    • Oxidized ca (2+)/calmodulin-dependent protein kinase II triggers atrial fibrillation
    • Purohit A, Rokita AG, Guan X, Chen B, Koval OM, Voigt N et al. Oxidized ca (2+)/calmodulin-dependent protein kinase ii triggers atrial fibrillation. Circulation. 2013;128:1748-1757.
    • (2013) Circulation , vol.128 , pp. 1748-1757
    • Purohit, A.1    Rokita, A.G.2    Guan, X.3    Chen, B.4    Koval, O.M.5    Voigt, N.6
  • 36
    • 84878725609 scopus 로고    scopus 로고
    • Oxidative stress in atrial fibrillation: An emerging role of NADPH oxidase
    • Youn JY, Zhang J, Zhang Y, Chen H, Liu D, Ping P et al. Oxidative stress in atrial fibrillation: An emerging role of NADPH oxidase. J Mol Cell Cardiol. 2013;62:72-79.
    • (2013) J Mol Cell Cardiol. , vol.62 , pp. 72-79
    • Youn, J.Y.1    Zhang, J.2    Zhang, Y.3    Chen, H.4    Liu, D.5    Ping, P.6
  • 37
    • 0037180407 scopus 로고    scopus 로고
    • Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation: Potential mechanisms for atrial thrombosis and stroke
    • Cai H, Li Z, Goette A, Mera F, Honeycutt C, Feterik K, et al. Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation: Potential mechanisms for atrial thrombosis and stroke. Circulation. 2002;106:2854-2858.
    • (2002) Circulation , vol.106 , pp. 2854-2858
    • Cai, H.1    Li, Z.2    Goette, A.3    Mera, F.4    Honeycutt, C.5    Feterik, K.6
  • 39
    • 54149088882 scopus 로고    scopus 로고
    • Differential effects of arginine methylation on diastolic dysfunction and disease progression in patients with chronic systolic heart failure
    • Wilson Tang WH, Tong W, Shrestha K, Wang Z, Levison BS, Delfraino B et al. Differential effects of arginine methylation on diastolic dysfunction and disease progression in patients with chronic systolic heart failure. Eur Heart J. 2008;29:2506-2513.
    • (2008) Eur Heart J , vol.29 , pp. 2506-2513
    • Wilson Tang, W.H.1    Tong, W.2    Shrestha, K.3    Wang, Z.4    Levison, B.S.5    Delfraino, B.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.